Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 12, 2007. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility under the company's Share Reward Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to reporting specific share transactions and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details the acquisition of Ordinary shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on December 11, 2007, at a price of GBP 13.00 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, or discussion of risks and contingencies. It strictly complies with Disclosure and Transparency Rule 3.1.4R(1)(a) regarding director share interests.
Investor Verification Points
- Verify the total number of shares acquired by each director (10 shares via personal contribution and 10 via company matching for each individual).
- Confirm the transaction price of GBP 13.00 per Ordinary share.
- Note that this filing does not reflect broader company financial performance for the period.